US 10280422
MiR-92 inhibitors and uses thereof
granted A61PA61P17/02A61P3/10
Quick answer
US patent 10280422 (MiR-92 inhibitors and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MIRAGEN THERAPEUTICS, INC.
- Grant date
- Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61P, A61P17/02, A61P3/10, A61P9/00, A61P9/10